DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Weigel B, Malempati S, Reid JM, Voss SD, Cho SY, Chen HX. et al.
Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: A report from the Children’s Oncology Group.
Pediatr Blood Cancer 2014;
61: 452-6
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.